Infinx has acquired MedReceivables Advisor to enhance its pathology revenue cycle management solutions, thereby bolstering support for healthcare providers.

Information on the Target

Infinx has recently acquired MedReceivables Advisor (MRA), a prominent player in pathology billing and revenue cycle management for hospital-based medical practices. This acquisition is expected to significantly enhance the range of services offered to Infinx clients, thereby providing better support for healthcare providers and alleviating their administrative challenges. MRA's robust expertise in pathology will enable Infinx to offer more advanced solutions, specifically tailored to the needs of pathology coding and billing.

MRA is renowned for its adeptness in various critical services, including litigation support, managed care contracting, credentialing assistance, payer contract evaluations, and monitoring fee schedules. Additionally, MRA excels in eligibility verification, accounts receivable, denial management, and providing legal support, which are crucial elements that align with Infinx's broader mission of optimizing revenue capture for healthcare organizations.

Industry Overview in the Target's Specific Country

The healthcare industry in the United States is undergoing a transformative phase driven by technological advancements and increasing regulatory demands. The integration of artificial intelligence and sophisticated billing solutions is becoming essen